newsfilter
← Latest News
Business Wire·

Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform

U.S. Patent No. 12,692,476 Has an Expected Expiration Date of June 9, 2043 Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel, allogeneic, "off